APT vs RTX

APT exhibits a weak deterministic health profile with a Piotroski F-Score of 3/9, indicating significant operational deterioration. While the company maintains an exceptionally strong balance sheet with low debt and high liquidity (Current Ratio 12.94), this is offset by stagnant revenue growth (0.30%) and declining earnings (-19.10% YoY). The stock trades below its Graham Number ($6.77) and book value (P/B 0.73), but its intrinsic value is estimated much lower at $2.31 due to poor growth prospects. Combined with bearish insider activity and a negative technical trend, the company appears to be a value trap.

RTX exhibits stable financial health with a Piotroski F-Score of 5/9, yet it is trading at a severe premium compared to its Graham Number ($73.73) and Intrinsic Value ($96.67). While the company boasts an exceptional track record of earnings beats over 25 quarters and solid revenue growth, the valuation is stretched with a PEG ratio of 2.75. This fundamental overvaluation is compounded by bearish insider sentiment and a weak technical trend, suggesting that while the business is strong, the stock price is currently decoupled from its deterministic value.